RME.F ResMed Inc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
213.60 EUR
Close of Nov 13, 2026
154.78 233.57
Market cap
EUR 30.0B
P/E
22.6x
P/B
5.52x
ROE
28.1%
Dividend yield
1.13%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.

Is RME.F undervalued?

Graham number
Price213.60
Graham value90.71
Premium135.5%

RME.F trades 135.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ResMed Inc fundamental analysis

No fundamental analysis for ResMed Inc yet.

ResMed Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ResMed Inc

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl…

Full company profile